Related references
Note: Only part of the references are listed.The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function
Shih-Chieh Lin et al.
AGING CELL (2013)
Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
Hind Hafsi et al.
BMC CANCER (2013)
Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis
Arijana Zoric et al.
CARCINOGENESIS (2013)
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression
H. Bernard et al.
ONCOGENE (2013)
Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
Elisabeth Silden et al.
PLOS ONE (2013)
The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer
Gerda Hofstetter et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Tania L. Slatter et al.
BLOOD (2011)
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
Kelly A. Avery-Kiejda et al.
BMC CANCER (2011)
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer
Michelle W. Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer
Kazuteru Oshima et al.
CANCER LETTERS (2011)
G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms
Virginie Marcel et al.
CARCINOGENESIS (2011)
Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Charles Coutant et al.
CLINICAL CANCER RESEARCH (2011)
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
Chun-Ju Chang et al.
NATURE CELL BIOLOGY (2011)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos
William R. Davidson et al.
BMC DEVELOPMENTAL BIOLOGY (2010)
Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
Virginie Marcel et al.
FEBS LETTERS (2010)
Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
Erica Ungewitter et al.
GENES & DEVELOPMENT (2010)
Endoplasmic Reticulum Stress Induces G2 Cell-Cycle Arrest via mRNA Translation of the p53 Isoform p53/47
Karima Bourougaa et al.
MOLECULAR CELL (2010)
Triple-negative breast cancer: Present challenges and new perspectives
Franca Podo et al.
MOLECULAR ONCOLOGY (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
H. C. Moore et al.
ONCOGENE (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
G. Hofstetter et al.
ONCOGENE (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
Kaori Fujita et al.
NATURE CELL BIOLOGY (2009)
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
Shu-Ping Wang et al.
NATURE CELL BIOLOGY (2009)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47
Darren J. Powell et al.
CELL CYCLE (2008)
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin
Kelly A. Avery-Kiejda et al.
CLINICAL CANCER RESEARCH (2008)
Impaired p53 function leads to centrosome amplification, acquired ERα phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts
A. B. D'Assoro et al.
ONCOGENE (2008)
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility?: A large pooled series from the breast cancer association consortium
Marjanka K. Schmidt et al.
CANCER RESEARCH (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
S. A. Mehta et al.
ONCOGENE (2007)
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
Mingxuan Xia et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Expression of p53 isoforms in squamous cell carcinoma of the head and neck
Linda Boldrup et al.
EUROPEAN JOURNAL OF CANCER (2007)
p53 downstream target genes and tumor suppression: a classical view in evolution
L. M. Rozan et al.
CELL DEATH AND DIFFERENTIATION (2007)
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia
Nina Anensen et al.
CLINICAL CANCER RESEARCH (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
The transcriptional targets of p53 in apoptosis control
J Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Modulation of mammalian life span by the short isoform of p53
B Maier et al.
GENES & DEVELOPMENT (2004)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Tumor suppressor p53 and its homologue p73α affect cell migration
AA Sablina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
S Courtois et al.
ONCOGENE (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
P53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
YL Yin et al.
NATURE CELL BIOLOGY (2002)
Share Paper
